Literature DB >> 10444338

Tumor necrosis factor receptors encoded by poxviruses.

K M Cunnion1.   

Abstract

Poxviruses encode several cytokine response modifying (Crm) proteins. The Crm proteins possess sequence homology to several human proteins important in immunity. This homology and the conservation of Crm proteins among poxvirus strains suggest an immunomodulatory function that provides a survival advantage to the virus. Cowpox virus encodes several tumor necrosis factor (TNF) receptor family homologues: CrmB, CrmC, and CrmD. CrmB and CrmD encode a similar approximately 155 amino acid COOH-terminus region distal to their TNF ligand-binding portions. These C-terminus regions contain no significant homology with sequences in public databases. It is not known whether the C-terminus regions have a complementary function to the TNF ligand-binding domains, or an unrelated function. Myxoma virus, a rabbit poxvirus, encodes a protein termed T2 which is homologous to CrmB and CrmD. Deletion of the T2 gene results in decreased pathogenicity of myxoma in rabbits. T2 has also been shown to interfere with TNF-induced apoptosis in vitro. Understanding the role viral TNF receptor homologues play in altering host immune responses may suggest ways to develop specific anti-inflammatory therapeutics. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10444338     DOI: 10.1006/mgme.1999.2878

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  11 in total

1.  Species-level identification of orthopoxviruses with an oligonucleotide microchip.

Authors:  Sergey Lapa; Maxim Mikheev; Sergei Shchelkunov; Vladimir Mikhailovich; Alexander Sobolev; Vladimir Blinov; Igor Babkin; Alexander Guskov; Elena Sokunova; Alexander Zasedatelev; Lev Sandakhchiev; Andrei Mirzabekov
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

Review 2.  Poxvirus immunomodulatory strategies: current perspectives.

Authors:  J B Johnston; Grant McFadden
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

3.  The interaction between human papillomavirus type 16 and FADD is mediated by a novel E6 binding domain.

Authors:  Sandy S Tungteakkhun; Maria Filippova; Jonathan W Neidigh; Nadja Fodor; Penelope J Duerksen-Hughes
Journal:  J Virol       Date:  2008-07-16       Impact factor: 5.103

4.  A secreted high-affinity inhibitor of human TNF from Tanapox virus.

Authors:  Craig R Brunetti; Mini Paulose-Murphy; Rajkumari Singh; Jing Qin; John W Barrett; Aubry Tardivel; Pascal Schneider; Karim Essani; Grant McFadden
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-03       Impact factor: 11.205

5.  Insights into ligand binding by a viral tumor necrosis factor (TNF) decoy receptor yield a selective soluble human type 2 TNF receptor.

Authors:  Sergio M Pontejo; Carolina Sanchez; Begoña Ruiz-Argüello; Antonio Alcami
Journal:  J Biol Chem       Date:  2019-02-05       Impact factor: 5.157

6.  The full-length isoform of human papillomavirus 16 E6 and its splice variant E6* bind to different sites on the procaspase 8 death effector domain.

Authors:  Sandy S Tungteakkhun; Maria Filippova; Nadja Fodor; Penelope J Duerksen-Hughes
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

7.  The host response to smallpox: analysis of the gene expression program in peripheral blood cells in a nonhuman primate model.

Authors:  Kathleen H Rubins; Lisa E Hensley; Peter B Jahrling; Adeline R Whitney; Thomas W Geisbert; John W Huggins; Art Owen; James W Leduc; Patrick O Brown; David A Relman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-11       Impact factor: 11.205

Review 8.  How vaccinia virus has evolved to subvert the host immune response.

Authors:  Mohammad W Bahar; Stephen C Graham; Ron A-J Chen; Samantha Cooray; Geoffrey L Smith; David I Stuart; Jonathan M Grimes
Journal:  J Struct Biol       Date:  2011-03-17       Impact factor: 2.867

9.  Stunned silence: gene expression programs in human cells infected with monkeypox or vaccinia virus.

Authors:  Kathleen H Rubins; Lisa E Hensley; David A Relman; Patrick O Brown
Journal:  PLoS One       Date:  2011-01-18       Impact factor: 3.240

10.  A method for the generation of ectromelia virus (ECTV) recombinants: in vivo analysis of ECTV vCD30 deletion mutants.

Authors:  Ali Alejo; Margarida Saraiva; Maria Begoña Ruiz-Argüello; Abel Viejo-Borbolla; Mar Fernández de Marco; Francisco Javier Salguero; Antonio Alcami
Journal:  PLoS One       Date:  2009-04-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.